1212 EXPOSURE-RESPONSE ANALYSES OF PEGYLATED INTERFERON LAMBDA (LAMBDA, BMS-914143) IN PATIENTS WITH CHRONIC HCV INFECTION: DOSE SELECTION FOR PHASE 3 CLINICAL TRIALS

Journal of Hepatology ◽

10.1016/s0168-8278(12)61224-0 ◽

2012 ◽

Vol 56 ◽

pp. S481

Author(s):

X. Wang ◽

P. Chan ◽

A. Ahmad ◽

J. Freeman ◽

A. Horga ◽

...

Keyword(s):

Clinical Trials ◽

Pegylated Interferon ◽

Hcv Infection ◽

Dose Selection ◽

Phase 3 ◽

Infection Dose ◽

Exposure Response ◽

Chronic Hcv Infection ◽

Selection For ◽

Download Full-text

804 EXPOSURE–RESPONSE ANALYSES OF ASUNAPREVIR IN COMBINATION WITH DACLATASVIR PEGINTERFERON/ RIBAVIRIN AMONG PATIENTS WITH GENOTYPE 1 CHRONIC HCV INFECTION: DOSE SELECTION FOR PHASE 3 CLINICAL TRIALS

Journal of Hepatology ◽

10.1016/s0168-8278(13)60806-5 ◽

2013 ◽

Vol 58 ◽

pp. S328-S329 ◽

Author(s):

P. Chan ◽

E. Tafoya ◽

T. Eley ◽

B. He ◽

P. Mendez ◽

...

Keyword(s):

Clinical Trials ◽

Hcv Infection ◽

Dose Selection ◽

Phase 3 ◽

Infection Dose ◽

Exposure Response ◽

Chronic Hcv Infection ◽

Selection For ◽

Download Full-text

A comprehensive evaluation of exposure–response relationships in clinical trials: application to support guselkumab dose selection for patients with psoriasis

Journal of Pharmacokinetics and Pharmacodynamics ◽

10.1007/s10928-018-9581-1 ◽

2018 ◽

Vol 45 (4) ◽

pp. 523-535 ◽

Author(s):

Chuanpu Hu ◽

Zhenling Yao ◽

Yang Chen ◽

Bruce Randazzo ◽

Liping Zhang ◽

...

Keyword(s):

Clinical Trials ◽

Comprehensive Evaluation ◽

Dose Selection ◽

Exposure Response ◽

Download Full-text

Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials

Gastroenterology ◽

10.1053/j.gastro.2017.03.047 ◽

2017 ◽

Vol 153 (1) ◽

pp. 113-122 ◽

Author(s):

Ira M. Jacobson ◽

Eric Lawitz ◽

Edward J. Gane ◽

Bernard E. Willems ◽

Peter J. Ruane ◽

...

Keyword(s):

Randomized Trials ◽

Hcv Infection ◽

Phase 3 ◽

Chronic Hcv Infection ◽

Download Full-text

901 ADDING SIMEPREVIR (TMC435) TO PEGYLATED INTERFERON/ RIBAVIRIN DOES NOT INCREASE PATIENT REPORTED FATIGUE IN TREATMENT-EXPERIENCED PATIENTS WITH CHRONIC HCV INFECTION: RESULTS FROM THE ASPIRE TRIAL

Journal of Hepatology ◽

10.1016/s0168-8278(13)60903-4 ◽

2013 ◽

Vol 58 ◽

pp. S371

Author(s):

J. Scott ◽

K. Rosa ◽

S. Zeuzem ◽

M. Beumont-Mauviel ◽

M. Peeters ◽

...

Keyword(s):

Pegylated Interferon ◽

Hcv Infection ◽

Patient Reported ◽

Chronic Hcv Infection ◽

Download Full-text

Pegylated interferon alpha-2a for treatment of chronic HCV infection in hemodialysis patients: a single Saudi center experience

International Urology and Nephrology ◽

10.1007/s11255-010-9756-1 ◽

2010 ◽

Vol 43 (3) ◽

pp. 865-873 ◽

Author(s):

Khalid Alsaran ◽

Alaa Sabry ◽

Naila Shaheen

Keyword(s):

Interferon Alpha ◽

Pegylated Interferon ◽

Hemodialysis Patients ◽

Hcv Infection ◽

Pegylated Interferon Alpha ◽

Chronic Hcv Infection ◽

Download Full-text

Efficacy of pegylated interferon and ribavirin for retreatment of chronic HCV infection in HIV co-infected patients failing a previous standard interferon-based regimen

Journal of Antimicrobial Chemotherapy ◽

10.1093/jac/dkn262 ◽

2008 ◽

Vol 62 (4) ◽

pp. 793-796 ◽

Author(s):

M. Crespo ◽

J. A. Mira ◽

J. A. Pineda ◽

E. V. d. Eynde ◽

M. J. Rios-Villegas ◽

...

Keyword(s):

Pegylated Interferon ◽

Hcv Infection ◽

Standard Interferon ◽

Chronic Hcv Infection ◽

Download Full-text

Fatigue Severity Scale: Reliability, Validity And Interpretation Of Change -- Evidence From Two Clinical Trials In Patients With Chronic Hcv Infection

Value in Health ◽

10.1016/j.jval.2013.03.1094 ◽

2013 ◽

Vol 16 (3) ◽

pp. A216 ◽

Author(s):

J. Scott ◽

K. Rosa ◽

M. Fu ◽

K. Cerri ◽

M. Peeters ◽

...

Keyword(s):

Clinical Trials ◽

Hcv Infection ◽

Fatigue Severity Scale ◽

Severity Scale ◽

Scale Reliability ◽

Fatigue Severity ◽

Chronic Hcv Infection ◽

Chronic Hcv ◽

Interpretation Of Change

Download Full-text

IRREVERSIBLE ALOPECIA UNIVERSALIS DURING TREATMENT WITH PEGYLATED INTERFERON AND RIBAVIRIN FOR CHRONIC HCV INFECTION

Digestive and Liver Disease ◽

10.1016/s1590-8658(09)60298-x ◽

2009 ◽

Vol 41 ◽

pp. S114

Author(s):

B. Omazzi ◽

G. Borroni ◽

A. Bortoli ◽

A. Prada

Keyword(s):

Pegylated Interferon ◽

Hcv Infection ◽

Alopecia Universalis ◽

Chronic Hcv Infection ◽

Download Full-text

Faculty Opinions recommendation of Efficacy of 8 weeks of sofosbuvir, velpatasvir, and voxilaprevir in patients with chronic HCV infection: 2 phase 3 randomized trials.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727490712.793568735 ◽

2019 ◽

Author(s):

George Cholankeril

Keyword(s):

Randomized Trials ◽

Hcv Infection ◽

Phase 3 ◽

Chronic Hcv Infection ◽

Download Full-text

The Cost-Effectiveness Analysis of Two Pegylated Interferon ALFA Treatment for Chronic HCV Infection in China

Value in Health ◽

10.1016/j.jval.2014.08.521 ◽

2014 ◽

Vol 17 (7) ◽

pp. A806

Author(s):

G. Liu ◽

L. Wei ◽

F. Xu ◽

Q. Xu ◽

X. You

Keyword(s):

Cost Effectiveness ◽

Pegylated Interferon ◽

Cost Effectiveness Analysis ◽

Interferon Alfa ◽

Hcv Infection ◽

Effectiveness Analysis ◽

Chronic Hcv Infection ◽

Pegylated Interferon Alfa ◽

Chronic Hcv ◽

Download Full-text